Updates on the NICE Guidance following the August 2024 meeting. The Final Draft Guidance is now anticipated in December 2024 with updates on extending the statutory 3-month funding period. Final recommendations on tirzepatide as a treatment option have been confirmed.
I was just looking atf the NICE Guidance to see where it's up to and noticed documents have been added. The committee's final recommendation on tirzepatide for managing overweight and obesity has been confirmed.
NHS England has requested that NICE vary the funding requirement timeframe as only one ICB felt they could meet the 3 month requirement proposed when surveyed.
https://www.nice.org.uk/guidance/indevelopment/gid-ta11156/documents
Funding variation request https://www.nice.org.uk/guidance/gid-ta11156/documents/html-content-10
(Annex B) Template treatment m0del for tirzepatide
(Annex C) Impact of tirzepatide recommendation without variation
(Annex D) Implementation proposal
(Annex E) Summary of equalities considerations
(Annex F) ICB Survey analysis
(Annex G) Specialist Weight Management Services Survey
(Appendix 2) Treatment Model